Toronto-based Exact Imaging and Cambridge, U.K.-based Cambridge Consultants have announced a new international partnership focused on improving the way specialists visualize and detect prostate cancer.

Exact Imaging’s ExactVu micro-ultrasound platform, allows urologists to assess suspicious regions and target those regions during biopsy. Cambridge Consultants, meanwhile, is using its years of experience working with artificial intelligence and deep learning, along with images secured using the ExactVu platform, to provide specialists with new and improved information.

The companies say their goal is to improve providers’ accuracy and ability to diagnose suspicious regions when treating prostate cancer patients, improving the overall quality of care.

“The need for effective management of prostate cancer is as pressing as ever,” Shweta Gupta, head of urology and women’s health at Cambridge Consultants, said in a prepared statement. “We are proud to have the opportunity to try and improve the detection pathway and excited by the opportunity to apply deep learning to this significant clinical problem.”